Variations were also observed in HDAC3 staining among different WHO subtypes, as nuclear immunoreactivity was less frequent in the more aggressive thymic carcinomas, compared to the rest of the TETs categories (Fisher exact test, p = 0.044). Here, HDAC3 is linked to thymic carcinoma.